Further to the outlook statement given in December 2016, revenue and trading year to date has continued to be ahead of the equivalent period and remains in line with management's expectations.
Back to All News
All Market News
Other Market News
Renishaw – Final Results
Diageo Announce Directorate Change
AstraZeneca’s Trixeo Approved in EU for Asthma
B.P. Marsh – Trading Update
HG Capital Trust – Half Year Report & Dividend Declaration
GlobalData – Half Year Results 2026
Sign up for our Stock News Highlights
Delivered to your inbox every Friday